Professional Documents
Culture Documents
MANAGEMENT IN PAKISTAN
BURDEN OF ASTHMA
ASTHMA IS ONE OF THE MOST
COMMON CHRONIC DISEASE
WORLDWIDE
PREVALENCE INCREASING IN MANY
COUNTRIES ESPECIALLY IN CHILDREN
OVER 300 MILLION ASTHMATIC
WORLDWIDE
GLOBAL ECONOMIC COST EXCEED
THAT OF TB HIV COMBINED
SOURCE :CHEST JULY 2006
SOCIAL STIGMA
IT IS NOT A CONTAGIOUS DISORDER
PATIENTS DO NOT ACCEPT
DIAGNOSIS DUE TO DISCRIMINATION
IN SOCIETY
DIAGNOSIS OF ASTHMA
PATIENTS ARE OFTEN MISDIAGNOSED
AS HAVING CHEST INFECTIONS OR
BRONCHITIS
IGNORANCE ABOUT THE DISEASE IS
COMMON AMONGST ASTHMA
PATIENTS AS WELL AS DOCTORS
MISUSE OF STEROIDS
CORTICOSTEROIDS ARE THE MOST
COMMON MEDICATIONS FOR ASTHMA
MANAGEMENT WHICH IS BEING USED
THROUGHOUT THE WORLD.IT
SHOULD BE GIVEN IN INHALER FORM
EIGHTY SEVEN PERCENT (87%)
ASTHMA PATIENTS HAVE NEVER
TAKEN OR HEARD ABOUT INHALED
CORTICOSTEROIDS
MISCONCEPTIONS ABOUT
INHALERS
INHALER DEVICES ARE THE BEST
METHOD OF DELIVERING ASTHMA
MEDICATIONS
THERE ARE MANY MISCONCEPTIONS
ABOUT INHALERS AMONGST ASTHMA
PATIENTS AND DOCTORS
POOR TECHNIQUE OF
INHALERS
EIGHTY PERCENT(80%) OF
ASTHMATICS IN PAKISTAN STILL USE
SYSTEMIC THERAPY i.e. ORAL AND
PARENTAL
EVEN THOSE ON INHALED
MEDICATIONS OVER 90% ARE ON
INHALED BRONCHODILATORS AND
ONLY 10% ARE ON INHALED
CORTICOSTEROID THERAPY
EXCESSIVE USE OF
NEBULIZERS
PATIENTS MAY USE THEIR NEBULIZER
REPEATEDLY AND DELAY SEEKING
MEDICAL HELP IN SEVERE ASTHMA. IT
IS SAID THAT
IF YOU NEED A NEBULIZER , THEN
YOU NEED TO SEE A DOCTOR
DESENSITIZATION VACCINES
AND ASTHMA
IMMUNOTHERAPY HAS PROVEN NOT
TO BE OF MAJOR BENEFIT IN ASTHMA
AND THERE IS ALSO A RISK OF
DEVELOPING SERIOUS ALLERGIC
REACTIONS TO THE INJECTIONS
DISSEMINATION OF
GUIDELINES AND
ADHERENCE TO GUIDELINES
THE DEVELOPMENT OF GUIDELINES
IS A LABOURIOUS PROCESS AND ITS
DISSEMINATION AMONGST
RESEARCHERS, DOCTORS AND
PATIENTS IS A DIFFICULT TASK
COST OF TREATMENT
COST OF TREATMENT OF INHALED
CORTICOSTEROIDS IS A BIG
CHALLENGE AND NEED TO BE
TACKELED
DOCTORS HAVE A RESPONSIBILITY TO
USE MEDICATIONS APPROPRIATELY
BECAUSE OF THE HIGH COST
INVOLVED